ANAEMIA
Iron deficiency anaemia
Through
its unique range of products and global presence, Vifor Pharma is the ideal partner to challenge iron deficiency world-wide.
The
WHO classifies iron deficiency as one of the most prevalent nutrient
deficiencies in the world, involving an estimated population of two
billion and causing almost one million deaths per year. Children and
their mothers are most commonly and severely affected because of the
high iron demands required during infant growth and pregnancy.
In
addition, there is an increasing number of other population groups such
as: hemodialysis, chemotherapy and chronic disease patients, who
require regular administration of injectable iron.
The therapeutic areas of Vifor Pharma in iron deficiency anaemia:
Cardiology
Gastroenterology
Hemodialysis
Oncology
Surgery